Related Experiment Video
Updated: Jul 10, 2026
07:47
Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Fluoromethylcholine PET in recurrent multifocal hepatoma
N P Lenzo1, J Anderson, A Campbell
1WA PET/Cyclotron Service, Sir Charles Gairdner Hospital, Perth, Australia. nlenzo@mac.com
Australasian Radiology
|January 3, 2008
Abstract:
F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has variable efficacy in evaluating hepatocellular carcinoma. We present a case of a new oncologic imaging tracer fluoromethylcholine (FCH), which has visualized recurrent multifocal hepatoma in a patient with a poor FDG avid hepatic tumour. The lesions demonstrated on FCH PET correlated well with the findings on CT hepatic angiography.
